Results 141 to 150 of about 4,182 (214)

Dystrophia unguium mediana canaliformis Heller. [PDF]

, 1974
Putz, Reinhard, Wohlfahrt, B., Zelger, J.   +2 more
core   +1 more source

Emerging Novel Biomarkers for Arteriosclerosis Obliterans

Journal of Atherosclerosis and Thrombosis, 2016
Takahiro, Horie, Takeshi, Kimura, Koh, Ono   +2 more
openaire   +3 more sources

Antisense long non‑coding RNA WEE2‑AS1 regulates human vascular endothelial cell viability via cell cycle G2/M transition in arteriosclerosis obliterans. [PDF]

Mol Med Rep, 2020
Jiang B, Wang R, Lin Z, Ma J, Cui J, Wang M, Liu R, Wu W, Zhang C, Li W, Wang S.   +10 more
europepmc   +1 more source

Etiology and pathophysiology of chronic transplant dysfunction [PDF]

, 2000
Bruin, R.W.F. (Ron) de, IJzermans, J.N.M. (Jan), Kouwenhoven, E.A. (Ewout)   +2 more
core   +2 more sources

Pentoxifylline for intermittent claudication [PDF]

, 2015
Abdel-Hadi, M., Booth, A., Forster, R., Michaels, J.A., Salhiyyah, K., Senanayake, E.   +5 more
core   +1 more source

Biostatistics and Clinical Epidemiology [PDF]

, 2010
折笠 秀樹, 熊谷 直子, 角 重喜
core   +1 more source

Clinical improvement after treatment with VEGF in patients with severe chronic lower limb ischaemia [PDF]

core   +1 more source

Efficacy of trimetazidine and plasmin combined with alprostadil in treatment of lower extremity arteriosclerosis obliterans. [PDF]

Exp Ther Med, 2019
Yong J, Wang Y, Xing S, Bi Y, Li N, Zhao S.   +5 more
europepmc   +1 more source

Comparison of efficacy between trimetazidine and cilostazol in the treatment of arteriosclerosis obliterans in lower extremity. [PDF]

Exp Ther Med, 2019
Hu M, Wang D, He T.
europepmc   +1 more source